Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Editing | 4 | 2012 | 33 | 0.870 |
Why?
|
| Adenosine | 5 | 2012 | 126 | 0.840 |
Why?
|
| Inosine | 4 | 2012 | 11 | 0.810 |
Why?
|
| Rett Syndrome | 2 | 2023 | 289 | 0.650 |
Why?
|
| Alu Elements | 4 | 2012 | 64 | 0.540 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2023 | 306 | 0.540 |
Why?
|
| Embryonic Stem Cells | 4 | 2013 | 172 | 0.520 |
Why?
|
| Brain | 4 | 2024 | 2946 | 0.270 |
Why?
|
| Adenosine Deaminase | 3 | 2013 | 74 | 0.220 |
Why?
|
| Alternative Splicing | 3 | 2018 | 345 | 0.220 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 11 | 0.200 |
Why?
|
| Radiation Protection | 1 | 2022 | 54 | 0.200 |
Why?
|
| Radiation Exposure | 1 | 2022 | 43 | 0.190 |
Why?
|
| Organoids | 1 | 2024 | 277 | 0.190 |
Why?
|
| Antigens, Differentiation | 1 | 2021 | 63 | 0.180 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2021 | 63 | 0.180 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 55 | 0.180 |
Why?
|
| Cell Differentiation | 5 | 2013 | 1907 | 0.180 |
Why?
|
| Space Flight | 1 | 2022 | 114 | 0.180 |
Why?
|
| Astrocytes | 1 | 2023 | 250 | 0.170 |
Why?
|
| RNA, Messenger | 3 | 2012 | 2814 | 0.170 |
Why?
|
| Open Reading Frames | 2 | 2010 | 211 | 0.170 |
Why?
|
| Neural Stem Cells | 1 | 2021 | 126 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 269 | 0.170 |
Why?
|
| Neurogenesis | 1 | 2021 | 196 | 0.160 |
Why?
|
| Genes, X-Linked | 1 | 2018 | 59 | 0.150 |
Why?
|
| Neurons | 3 | 2023 | 1927 | 0.140 |
Why?
|
| Embryonic Development | 2 | 2012 | 209 | 0.140 |
Why?
|
| Introns | 1 | 2018 | 302 | 0.140 |
Why?
|
| Mice | 7 | 2021 | 17486 | 0.130 |
Why?
|
| Gene Expression | 2 | 2018 | 1565 | 0.130 |
Why?
|
| Exons | 1 | 2018 | 795 | 0.120 |
Why?
|
| RNA-Binding Proteins | 4 | 2013 | 572 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 1116 | 0.120 |
Why?
|
| Blood Vessels | 2 | 2005 | 104 | 0.120 |
Why?
|
| Transcriptome | 2 | 2018 | 906 | 0.110 |
Why?
|
| Animals | 8 | 2022 | 33714 | 0.110 |
Why?
|
| Conserved Sequence | 2 | 2012 | 293 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2012 | 996 | 0.100 |
Why?
|
| Hippocampus | 1 | 2018 | 814 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 190 | 0.100 |
Why?
|
| Stem Cells | 3 | 2005 | 700 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3714 | 0.090 |
Why?
|
| Metabolome | 1 | 2012 | 292 | 0.080 |
Why?
|
| Templates, Genetic | 1 | 2009 | 95 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2010 | 237 | 0.080 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 63 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 256 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2009 | 160 | 0.080 |
Why?
|
| RNA | 1 | 2012 | 572 | 0.080 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 452 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2009 | 623 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4269 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 287 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 1 | 2009 | 375 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 2 | 2005 | 240 | 0.070 |
Why?
|
| Prosencephalon | 1 | 2024 | 40 | 0.060 |
Why?
|
| Humans | 13 | 2024 | 123184 | 0.050 |
Why?
|
| Teratoma | 1 | 2004 | 123 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2004 | 211 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 12 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2009 | 826 | 0.050 |
Why?
|
| Research Design | 1 | 2004 | 686 | 0.040 |
Why?
|
| Cell Line | 3 | 2010 | 2772 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2847 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2010 | 422 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 1265 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2005 | 400 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2012 | 3 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 2012 | 17 | 0.030 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 2012 | 10 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 350 | 0.030 |
Why?
|
| Filamins | 1 | 2012 | 25 | 0.030 |
Why?
|
| Guanylate Cyclase | 1 | 2012 | 37 | 0.030 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2012 | 43 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 67 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2012 | 88 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2012 | 63 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2012 | 70 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2012 | 71 | 0.020 |
Why?
|
| Methylation | 1 | 2012 | 226 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 1012 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 408 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2010 | 6 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 2528 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 276 | 0.020 |
Why?
|
| Computational Biology | 2 | 2005 | 798 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 554 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 878 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 531 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 5771 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 550 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 672 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 647 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 669 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2004 | 1681 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 505 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 3091 | 0.020 |
Why?
|
| Time Factors | 2 | 2008 | 6211 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 3046 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 3270 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 106 | 0.010 |
Why?
|
| Lymphangiogenesis | 1 | 2004 | 18 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 136 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2004 | 60 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2005 | 312 | 0.010 |
Why?
|
| Pluripotent Stem Cells | 1 | 2004 | 76 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 348 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 160 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2004 | 571 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 239 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 481 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 340 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2004 | 609 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 696 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 864 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 1291 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1781 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1682 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 527 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2004 | 533 | 0.010 |
Why?
|
| Biomarkers | 1 | 2004 | 2942 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 4227 | 0.010 |
Why?
|